Olmesartan/Hidroclorotiazida Viatris (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan/Hidroclorotiazida Viatris, is a angiotensin II receptor blocker presented as a oral tablet for hypertension management in adults. It combines olmesartan medoxil with hydrochlorothiazide to enhance blood pressure control.

GNH USA supplies Olmesartan/Hidroclorotiazida Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Hidroclorotiazida Viatris is used for hypertension, acting on the renin‑angiotensin system to lower elevated blood pressure. - Hypertension: Reduces systolic and diastolic blood pressure, decreasing cardiovascular risk. - Heart failure: Assists in managing fluid overload when combined with diuretics. - Diabetic nephropathy : Provides renal protection by controlling hypertension. - Chronic kidney disease : Slows progression by maintaining target blood‑pressure levels. - Post‑cardiac surgery : Supports blood‑pressure control during recovery.

Common Side Effects: -      ---   ---  ---  --- ---  ... ...  ...  ... … … … … … … … … … ... … ... ... ... ... ... ... ... ... ... ... ... ... ... ...

Serious or Rare ".  ...  .... "  ...  ... ":[ "  "  "  "  ... " "  … "  ... "" " … "  " " "" "" "" """}